A nem szteroid gyulladáscsökkentok cardiovascularis kockázata

Translated title of the contribution: Cardiovascular risk of nonsteroidal antiinflammatory drugs

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

During the past decade, a number of original publications, reviews and metaanalyses were published on the cardiovascular safety of nonsteroidal antiinflammatory drugs (NSAIDs). As this group of medicines is among the most frequently used ones and many preparations are available over the counter, it seems to be prudent to summarise the most important results on the safety of these drugs, and underline their potentially harmful cardiovascular side effects. Nevertheless, it can also be emphasized that there are substantial differences between different compounds, and the cardiovascular risk does not depend on the ratio of COX-1/COX-2 selectivity. Cardiovascular risk can be increased by all NSAIDs with the possible exception of naproxen.

Original languageHungarian
Pages (from-to)249-255
Number of pages7
JournalLege Artis Medicinae
Volume21
Issue number4
Publication statusPublished - Apr 2011

Fingerprint

Anti-Inflammatory Agents
Pharmaceutical Preparations
Safety
Naproxen
Publications

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A nem szteroid gyulladáscsökkentok cardiovascularis kockázata. / Farsang, C.

In: Lege Artis Medicinae, Vol. 21, No. 4, 04.2011, p. 249-255.

Research output: Contribution to journalArticle

@article{08390c24ab2e4ff2b8f5237633dce384,
title = "A nem szteroid gyullad{\'a}scs{\"o}kkentok cardiovascularis kock{\'a}zata",
abstract = "During the past decade, a number of original publications, reviews and metaanalyses were published on the cardiovascular safety of nonsteroidal antiinflammatory drugs (NSAIDs). As this group of medicines is among the most frequently used ones and many preparations are available over the counter, it seems to be prudent to summarise the most important results on the safety of these drugs, and underline their potentially harmful cardiovascular side effects. Nevertheless, it can also be emphasized that there are substantial differences between different compounds, and the cardiovascular risk does not depend on the ratio of COX-1/COX-2 selectivity. Cardiovascular risk can be increased by all NSAIDs with the possible exception of naproxen.",
keywords = "Cardiovascular risk, Nonsteroidal antiinflammatory drugs",
author = "C. Farsang",
year = "2011",
month = "4",
language = "Hungarian",
volume = "21",
pages = "249--255",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "4",

}

TY - JOUR

T1 - A nem szteroid gyulladáscsökkentok cardiovascularis kockázata

AU - Farsang, C.

PY - 2011/4

Y1 - 2011/4

N2 - During the past decade, a number of original publications, reviews and metaanalyses were published on the cardiovascular safety of nonsteroidal antiinflammatory drugs (NSAIDs). As this group of medicines is among the most frequently used ones and many preparations are available over the counter, it seems to be prudent to summarise the most important results on the safety of these drugs, and underline their potentially harmful cardiovascular side effects. Nevertheless, it can also be emphasized that there are substantial differences between different compounds, and the cardiovascular risk does not depend on the ratio of COX-1/COX-2 selectivity. Cardiovascular risk can be increased by all NSAIDs with the possible exception of naproxen.

AB - During the past decade, a number of original publications, reviews and metaanalyses were published on the cardiovascular safety of nonsteroidal antiinflammatory drugs (NSAIDs). As this group of medicines is among the most frequently used ones and many preparations are available over the counter, it seems to be prudent to summarise the most important results on the safety of these drugs, and underline their potentially harmful cardiovascular side effects. Nevertheless, it can also be emphasized that there are substantial differences between different compounds, and the cardiovascular risk does not depend on the ratio of COX-1/COX-2 selectivity. Cardiovascular risk can be increased by all NSAIDs with the possible exception of naproxen.

KW - Cardiovascular risk

KW - Nonsteroidal antiinflammatory drugs

UR - http://www.scopus.com/inward/record.url?scp=79956345484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956345484&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79956345484

VL - 21

SP - 249

EP - 255

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 4

ER -